Bone morphogenetic protein receptors and signal transduction
- PMID: 19762341
- DOI: 10.1093/jb/mvp148
Bone morphogenetic protein receptors and signal transduction
Abstract
Bone morphogenetic proteins (BMPs) exhibit broad spectra of biological activities in various tissues, including bone, cartilage, blood vessels, heart, kidney, neurons, liver and lung. BMPs are members of the transforming growth factor-beta (TGF-beta) family that bind to type II and type I serine-threonine kinase receptors, and transduce signals through Smad and non-Smad signalling pathways. Recent findings have revealed that BMP signalling is finely tuned by various mechanisms in both positive and negative fashions. Perturbations of BMP signalling pathways are linked to a wide variety of clinical disorders, including vascular diseases, skeletal diseases and cancer. Administration of recombinant BMP ligands and increasing endogenous expression of BMPs provide therapeutic effects on some diseases. The recent development of BMP receptor inhibitors may also prove useful for some clinical diseases induced by hyperactivation of the BMP signalling pathways.
Comment in
-
An impact of CCN2-BMP-2 complex upon chondrocyte biology: evoking a signalling pathway bypasses ERK and Smads?J Biochem. 2011 Sep;150(3):219-21. doi: 10.1093/jb/mvr089. Epub 2011 Jul 18. J Biochem. 2011. PMID: 21768122
Similar articles
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
-
Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.J Bone Miner Res. 2011 Jun;26(6):1178-87. doi: 10.1002/jbmr.313. J Bone Miner Res. 2011. PMID: 21611961
-
Structural insights into BMP receptors: Specificity, activation and inhibition.Cytokine Growth Factor Rev. 2016 Feb;27:13-34. doi: 10.1016/j.cytogfr.2015.11.005. Epub 2015 Nov 24. Cytokine Growth Factor Rev. 2016. PMID: 26690041 Review.
-
BMP signaling in vascular diseases.FEBS Lett. 2012 Jul 4;586(14):1993-2002. doi: 10.1016/j.febslet.2012.04.030. Epub 2012 May 3. FEBS Lett. 2012. PMID: 22710160 Review.
-
Bone Morphogenetic Proteins.Cold Spring Harb Perspect Biol. 2016 Jun 1;8(6):a021899. doi: 10.1101/cshperspect.a021899. Cold Spring Harb Perspect Biol. 2016. PMID: 27252362 Free PMC article. Review.
Cited by
-
Bone Morphogenetic Proteins and Diabetic Retinopathy.Biomolecules. 2021 Apr 18;11(4):593. doi: 10.3390/biom11040593. Biomolecules. 2021. PMID: 33919531 Free PMC article. Review.
-
Cinobufotalin prevents bone loss induced by ovariectomy in mice through the BMPs/SMAD and Wnt/β-catenin signaling pathways.Animal Model Exp Med. 2024 Jun;7(3):208-221. doi: 10.1002/ame2.12359. Epub 2023 Nov 28. Animal Model Exp Med. 2024. PMID: 38013618 Free PMC article.
-
Bone morphogenetic protein 2 promotes primordial follicle formation in the ovary.Sci Rep. 2015 Jul 29;5:12664. doi: 10.1038/srep12664. Sci Rep. 2015. PMID: 26219655 Free PMC article.
-
The Activation of the Fibrodysplasia Ossificans Progressiva-Inducing ALK2-R206H Mutant Depends on the Distinct Homo-Oligomerization Patterns of ACVR2B and ACVR2A.Cells. 2024 Jan 25;13(3):221. doi: 10.3390/cells13030221. Cells. 2024. PMID: 38334613 Free PMC article.
-
Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.Cancer Lett. 2015 Nov 1;368(1):79-87. doi: 10.1016/j.canlet.2015.07.032. Epub 2015 Jul 30. Cancer Lett. 2015. PMID: 26235139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
